CLINICAL_TRIALS
trial_result
· 2014-06-24
Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma [Phase 2]
Summary
A Phase 2 trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Basal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-06-24